Common Stock SEC Reporting - Current
Verified Company Profile 7/18/2017
Contact Info
  • 4203 SW 34th St
  • Orlando, FL 32811

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0000075439
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: DE, USA
Year of Inc. 1999
Employees 80 a/o Jul 17, 2017
Company Officers/Contacts
David E. Patterson CEO, Secretary
Susan Weisman CFO
Jeffrey Rencher Chief Marketing Officer
Stephen Von Rump Chief Strategy Officer
Company Directors
John Abeles
Eric M. Goehausen
W. Austin Lewis IV
Augusto Ocana
Company Notes
  • Formerly=CytoCore, Inc. until 12-2014
  • Formerly=Molecular Diagnostics, Inc. until 8-06
  • Formerly=Ampersand Medical Corp. until 9-01
  • Note=5-99 State of incorporation California changed to Delaware
  • Formerly=Bell National Corp. until 5-99
  • Formerly=Pacific Coast Holdings, Inc. to 1-83
  • Note=8-85 Company filed petition under Chapter XI of the Federal Bankruptcy Act.
Service Providers
Accounting/Auditing Firm
KMJ Corbin & Company LLP
2603 Main Street
Suite 600
Irvine, CA, 92614
United States

180 S. Orange #1150
Suite 1150
Orlando, FL, 32801
United States

Legal Counsel
O'Neal Law Firm
140 Sand Rock Road
Lewiston, PA, 17044
United States

Investor Relations Firm
Not Available
MDIT Security Details
Share Structure
Market Value1 $16,590,757 a/o Oct 20, 2017
Authorized Shares 50,000,000 a/o Oct 19, 2017
Outstanding Shares 27,651,262 a/o Oct 19, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC 1,589,941 a/o Oct 19, 2017
Float Not Available
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
Shareholders of Record 427 a/o Apr 14, 2017
Short Selling Data
Short Interest 1,030 (100%)
Jun 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security